C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof

Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
11/2011
11/01/2011	CA2531911C Specific glucocorticosteroid having an anti-inflammatory activity
10/2011
10/27/2011	US20110263640 8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2011	US20110263639 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/27/2011	US20110263570 Pyrimidine derivatives as gpcr modulators for use in the treatment of obesity and diabetes
10/26/2011	EP2380898A1 Process to make glucocortisoid compounds
10/26/2011	EP1518855B1 Diaminopyrimidinecarboxa mide derivative
10/26/2011	CN102227424A Modulators of cystic fibrosis transmembrane conductance regulator
10/25/2011	US8044045 Indazole-carboxamide compounds as 5-HT4 receptor agonists
10/20/2011	US20110257153 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/19/2011	EP2376489A1 Alkaloid aminoester derivatives and medicinal composition thereof
10/19/2011	EP2376449A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
10/19/2011	EP2018380B1 Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
10/19/2011	EP1957451B1 Soft anticholinergic zwitterions
10/19/2011	EP1948596B1 Soft anticholinergic esters
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/13/2011	US20110251192 Amide compounds, their pharmaceutical compositions, their preparation method and their uses
10/12/2011	EP2374455A2 Modulators of muscarinic receptors
10/12/2011	CN101616916B Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
10/06/2011	WO2011123080A1 Method for synthesis of tiotropium bromide
10/06/2011	WO2011123079A1 Synthesis method for producing tiotropium bromide
10/06/2011	WO2011123077A1 Tiotropium bromide preparation process
10/05/2011	EP2370407A1 Carbazole and carboline kinase inhibitors
10/05/2011	CN1938292B Cyclic amine compound and pest control agent
10/05/2011	CN1845933B Specific glucocorticosteriod compound having anti-inflamatory activity
09/2011
09/29/2011	WO2011116491A1 Preparation method for nortropine benzilate and its salts and intermediates used in said method
09/28/2011	CN102203089A N-sulfonamido polycyclic pyrazolyl compounds
09/27/2011	CA2415847C Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
09/22/2011	WO2010093706A8 Chemically programmed vaccination
09/22/2011	WO2009037111A3 Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions
09/20/2011	CA2482637C New esters of hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
09/20/2011	CA2471578C Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
09/15/2011	WO2011112825A2 Heterocyclyl-azabicyclo[3.2.1]octane analogs as selective m1 agonists and methods of making and using same
09/14/2011	EP2364705A2 Modulators of muscarinic receptors
09/14/2011	EP2364311A1 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1
09/14/2011	CN102183589A Method for detecting contents of dolasetron isomer and salt thereof
09/14/2011	CN102180878A Dolasetron isomer or salt thereof, preparation method for the Dolasetron isomer or salt thereof and application of the Dolasetron isomer or salt thereof
09/13/2011	CA2486869C Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
09/06/2011	US8012975 Antitumoral analogs of ET-743
09/06/2011	US8012959 Diaminopyrimidinecarboxamide derivative
09/06/2011	US8012956 Tropane compounds
09/01/2011	WO2011105506A1 Cyclic amine compound and miticide
09/01/2011	WO2011015882A3 Anhydrate of triotropium bromide
09/01/2011	WO2010149309A3 Cycloalkylamidobenzoxa(thia)zoles as fungicides
09/01/2011	CA2789645A1 Cyclic amine compound and acaricide
08/2011
08/31/2011	CN101384588B Process for preparing intermediates to 5-ht4 receptor agonist compounds
08/30/2011	US8008288 Anti-inflammatory A-aminocyclolactam compounds
08/24/2011	CN101787021B High-purified tropisetron hydrochloride compound
08/24/2011	CN101312967B Carbamate compounds as 5-ht4 receptor agonists
08/17/2011	CN102159572A Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
08/11/2011	WO2011096461A1 Quinoline derivative
08/11/2011	US20110195929 Compounds for the treatment of flaviviral infections
08/10/2011	EP2354124A2 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
08/10/2011	CN1972940B Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
08/10/2011	CN102146079A Preparation method of scopolamine butylbromide
08/10/2011	CN101351466B Heterocyclic Janus kinase 3 inhibitors
08/10/2011	CN101307051B Process for synthesizing and detecting scopolamine derivates
08/09/2011	US7994323 Chromen-2-one derivatives
08/09/2011	US7994188 Compounds for treating inflammatory diseases
08/09/2011	CA2512000C Selective estrogen receptor modulator
08/04/2011	WO2011093501A1 Gpr119 agonist
08/04/2011	WO2011092061A1 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/04/2011	US20110190503 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase
08/04/2011	US20110190262 Aryl-and Heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/03/2011	EP2350068A2 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
08/03/2011	EP2350045A1 C-met protein kinase inhibitors
08/02/2011	US7989470 3,8-substituted 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
07/2011
07/27/2011	EP2346863A2 N-sulfonamido polycyclic pyrazolyl compounds
07/27/2011	CN101696207B Tropine purification method and atropine production process
07/26/2011	CA2484482C Triple monoamine reuptake inhibitors for the treatment of chronic pain
07/21/2011	WO2011087652A1 Tropinone benzylamines as beta-tryptase inhibitors
07/21/2011	US20110178075 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
07/21/2011	US20110178055 Dual nk1/nk3 receptor antagonists
07/20/2011	CN102127069A Tiotropium bromide crystal
07/14/2011	US20110172264 Nicotinic acetylcholine receptor modulators
07/14/2011	US20110172239 Compounds, Compositions and Methods for the Treatment of Amyloid Diseases and Synucleinopathies such as Alzheimer's Disease, Type 2 Diabetes and Parkinson's Disease
07/13/2011	EP2158200B1 Novel chromen-2-one derivatives
07/13/2011	EP1432420B1 Benzimidazolidinone derivatives as muscarinic agents
07/12/2011	CA2487672C Industrial process for preparing tropenol
07/12/2011	CA2481268C Medicaments comprising steroids and a novel anticholinergic
07/07/2011	US20110166355 Process for preparing an intermediate to mu opioid receptor antagonists
07/06/2011	CN101151264B Crystalline form of a quinolinone-carboxamide compound
06/2011
06/30/2011	WO2011078306A1 Gpr119 agonist
06/30/2011	WO2011078081A1 Cyclic amine compound and acaricide
06/30/2011	WO2011076778A1 Radioiodinated tropane derivatives
06/28/2011	US7968717 Of tiotropium bromide; chronic obstructive pulmonary disease (COPD) and asthma; storage stability, only limited hygroscopic characteristics
06/28/2011	CA2467672C Chemokine receptor antagonists and methods of use therefor
06/23/2011	WO2011073256A1 Preparation of n-monofluoroalkyl tropanes
06/23/2011	US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
06/23/2011	CA2782945A1 Preparation of n-monofluoroalkyl tropanes
06/23/2011	CA2781390A1 Bridged bicyclic rho kinase inhibitor compounds, composition and use
06/22/2011	EP2336127A1 Tiotropium salts, method for creating same and medicinal formulations containing same
06/22/2011	EP2336126A1 Tiotropium salts, method for their production and medicinal formulas containing them
06/22/2011	EP2336125A1 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase
06/22/2011	EP2102157B1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/16/2011	US20110144151 Novel process, salts, composition and use
06/15/2011	EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation
06/15/2011	EP2331522A2 Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
06/15/2011	CN1956964B Tetrahydro-indazole cannabinoid modulators
06/15/2011	CN1930145B Cycloalkanopyridine derivative
06/15/2011	CN101445506B 3 alpha-high tropine aliphatic amine salt, crystal formation and preparation method

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 53